PMN

Promis Neurosciences Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↓ 4/10
  • Value↓ 4/10
Promis Neurosciences sales and earnings growth
PMN Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -656.00%
  • FCF Y/Y↓ -23.97%
Promis Neurosciences gross and profit margin trends
PMN Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ -1720.61%
Promis Neurosciences net debt vs free cash flow
PMN Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Promis Neurosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗